These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28933259)

  • 1. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
    Chen D; Liu D; Chen Z
    Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.
    Chen R; Li X; He B; Hu W
    Mol Med Rep; 2017 Mar; 15(3):1326-1334. PubMed ID: 28138700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma.
    Zhou C; Tan W; Lv H; Gao F; Sun J
    Cell Oncol (Dordr); 2016 Oct; 39(5):463-471. PubMed ID: 27376839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.
    Vanas V; Haigl B; Stockhammer V; Sutterlüty-Fall H
    PLoS One; 2016; 11(8):e0161023. PubMed ID: 27513462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
    Xu E; Zhao J; Ma J; Wang C; Zhang C; Jiang H; Cheng J; Gao R; Zhou X
    Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
    Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
    Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
    Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
    Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
    Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
    Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
    Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of microRNA in osteosarcoma and chondrosarcoma.
    Chang L; Shrestha S; LaChaud G; Scott MA; James AW
    Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    J Cell Mol Med; 2019 Apr; 23(4):2280-2292. PubMed ID: 30724027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
    Miao J; Wu S; Peng Z; Tania M; Zhang C
    Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA.
    Chen H; Gong Z; Zhou H; Han Y
    Drug Dev Res; 2024 Apr; 85(2):e22167. PubMed ID: 38444106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
    Cai T; Zhang C; Zhan T
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
    Ram Kumar RM; Boro A; Fuchs B
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.